Retapamulin (Altargo): novel antibacterial for impetigo
Authors
Abstract
Retapamulin is a new topical antibacterial licensed for impetigo and minor skin infections. In our New products review Steve Chaplin presents the clinical data relating to its efficacy and adverse effects, and Dr Cameron Kennedy comments on its place in therapy. Copyright © 2008 Wiley Interface Ltd
Digital Object Identifier (DOI)
10.1002/psb.272 About DOI
Login/Logout
Journal Menu
- Home
- News
- Current Issue
- Archive Issues
- Learning Central
- Ask Prescriber
- Prescriber Blog
- Forthcoming Events
- Supplements
- Wiley Job Network
Advertising and Sponsorship
Other Journals
